Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Headquarters
Batajnicki Drum Bb
Belgrade; Belgrade; Map
Postal Code: 11080
Tel: (+381 11) 307
Fax: (+381 11) 307 16
Email: @galenika.co.rs
Website: http://www.galenika.rs

Full name: Galenika A.D. Beograd

Status: Non-Listed
Legal Form: Joint Stock Company
Operational Status: Operational
EMISid: 1554180
YU-MB: 07726325
PIB: 100001038
Incorporation Date: 30-Apr-91

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Company Description

Galenika, a state-controlled firm established in 1945, was the first company in former Yugoslavia to be acquired by a foreign partner.
ICN Pharmaceuticals, which acquired a 75% stake in the drug maker under a 1990 agreement, planned to use it as a platform for growth in eastern Europe.
California-based ICN was owned at the time by Serb-born U.S. businessman Milan Panic, who returned to his native country in 1992 to briefly serve as Prime Minister.
Serbia's government took over the Belgrade plant of…

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Key Executives

Chairman of the Supervisory Board
More

Ownership Details

Republic of Serbia
70%

Key Stats

Select Items to chart them. 2015 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss)
Total assets 5,000,939
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Poslovni Plan DOO, EMIS Company Database.

Financials

Competitors - Serbia

RSD | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2015
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest